drugset / Trial / NCT03424629
Safety and Efficacy of UC-MSCs in Patients With Plaque Psoriasis
RandomizedCrossoverOpen-labelTreatment
Summary
This is a study in patients with moderate to severe chronic plaque psoriasis.All the participants will be randomized into three groups, high-dose UC-MSCs, low-dose UC-MSCs, or methotrexate group.This study is designed to prove that UC-MSCs is safe and effective.
Timeline
- Start
- 2018-06-01
- Primary completion
- 2018-09-30
- Completion
- 2019-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Methotrexate | Small molecule | — | Oral |
| Subject | mesenchymal stem cells | Cell therapy | 1e+06 cells/kg | — |
| Subject | mesenchymal stem cells | Cell therapy | 3e+06 cells/kg | — |